Brief: Callan JMB Signs Manufacturing Oversight, Federal Deployment, And Commercialization Agreement Of Multi-Asset Therapeutic Pipeline With Attune For Approximately $50 To $75 Million In Total Revenue
15/01/2026 14:03
Jan 15 (Reuters) - Callan JMB Inc CJMB.O: CALLAN JMB SIGNS MANUFACTURING OVERSIGHT, FEDERAL DEPLOYMENT, AND COMMERCIALIZATION AGREEMENT OF MULTI-ASSET THERAPEUTIC PIPELINE WITH ATTUNE FOR APPROXIMATELY $50 TO $75 MILLION IN TOTAL REVENUE Source text: ID:nGNX8VbWCC Further company coverage: CJMB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Callan JMB
See all newsBrief: Callan JMB Advances IV Bag Manufacturing Facility With Projected $450 Million In Annual Revenue
Brief: Callan JMB Says Callan Power LLC Terminates Asset Purchase Agreement With Pfanenstiel Company - SEC Filing
Brief: Callan Jmb Advances U.S. Pharmaceutical Manufacturing At The Atlas Complex And Expands Into North American Equipment Distribution And Assembly
Brief: Callan Jmb Inc. Regains Compliance With Nasdaq’S Minimum Bid Price Requirement
Brief: Callan Jmb Bia Power Systems, Asu Announce Joint Venture In Brewton, Alabama